- Release Date: 07/02/25 08:14
- Summary: Type C Meeting granted by FDA for Phelan-McDermid syndrome
- Price Sensitive: No
- Download Document 155.37KB
- Forums
- ASX - By Stock
- Ann: Type C Meeting granted by FDA for Phelan-McDermid syndrome
NEU
neuren pharmaceuticals limited
Add to My Watchlist
10.4%
!
$13.84

Ann: Type C Meeting granted by FDA for Phelan-McDermid syndrome
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.84 |
Change
1.300(10.4%) |
Mkt cap ! $1.559B |
Open | High | Low | Value | Volume |
$12.96 | $13.84 | $12.91 | $3.704M | 276.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 138 | $13.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.84 | 65 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 13.270 |
1 | 150 | 13.260 |
5 | 680 | 13.250 |
6 | 7776 | 13.240 |
3 | 411 | 13.230 |
Price($) | Vol. | No. |
---|---|---|
13.310 | 1530 | 3 |
13.320 | 436 | 3 |
13.330 | 2176 | 5 |
13.340 | 592 | 3 |
13.350 | 1092 | 3 |
Last trade - 10.23am 26/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online